Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas. by Heinemann, D. et al.
Br. J. Cancer (1987), 56, 433-437 .9 The Macmillan Press Ltd., 1987
Expression of histocompatibility antigens and characterisation of
mononuclear cell infiltrates in human renal cell carcinomas
D. Heinemann1, P.J.B. Smith2 and M.O. Symes'
Departments of 1Surgery and 2Urology, University ofBristol and Bristol and Weston District Health Authority, Bristol Royal
Infirmary, Bristol BS2 8HW, UK.
Summary Neoplastic tissue was obtained at operation from 10 renal cell carcinomas, from the adjacent
'normal' kidney in 6 cases and from 1 other normal kidney. The biopsies were snap frozen in liquid nitrogen
and sections were subsequently stained with monoclonal antibodies against major histocompatibility complex
(MHC) antigens, class I and II, and several types of mononuclear cell, by the indirect immunoperoxidase
method. The degree of staining or the number of cells stained was estimated as heavy 4, through moderate 3,
few 2, occasional 1, or nil 0. MHC Ag were consistently expressed, grade 2-4, by the glomeruli and proximal
convoluted tubules of normal kidney, but were absent in 8 of 10 carcinomas. There was a grade 3-4
mononuclear cell infiltration in the stroma of normal kidney and between the carcinoma cells which was
composed principally of macrophages. However in the two carcinomas expressing MHC Ag there was also a
grade 2-3 infiltration with T lymphocytes. The absence of MHC Ag on carcinoma cells mitigates against
attempts to potentiate the patient's immune response to his tumour, e.g. by renal artery embolisation.
Renal cell carcinomas account for 3% of all malignant
neoplasms and have an incidence of 4 per 100,000 persons
(Kantor, 1977). Whilst the 5 year survival rate following
radical nephrectomy was 62% in patients without meta-
stases, this fell to 13% for patients with metastases (Nurmi,
1984). Furthermore approximately 30% of patients have
metastases at the time of their initial diagnosis (Middleton,
1967).
The marked difference in prognosis depending on the
presence of metastases, together with the occurrence of
spontaneous remission in 1 of 200 patients with metastases
(Holland, 1973), have led to suggestions that an immune
response by the patient to the tumour may be important in
determining the clinical outcome (Woodruff, 1980). In an
attempt to potentiate this renal artery embolisation prior to
nephrectomy has been employed, but the majority of reports
show no benefit from this procedure (Kaisary et al., 1984). It
therefore seemed germane to study the expression of major
histocompatibility complex (MHC) antigens by renal cell
carcinoma cells and the degree and nature of the mono-
nuclear cell infiltrate in this neoplasm. To this end staining
with monoclonal antibodies reactive with the appropriate
antigens has been employed. The mononuclear cell infiltrates
and histocompatibility antigen expression were compared
between neoplastic tissue and an adjacent area of 'normal'
tissue from the tumour bearing kidney. Similar techniques
have been used to monitor the expression of MHC Ag in
neoplastic cells and to identify lymphocyte subsets among
mononuclear cells infiltrating melanomas (Kornstein et al.,
1983) and breast (Bahn & Des \4aris, 1983; Whitwell et al.,
1984), ovarian (Kabawat et al., 1983) and colorectal
(Umpleby et al., 1985) carcinomas.
Materials and methods
A 0.5 g specimen was obtained from the tumour in 10
patients, and in 6 of these a similar biopsy was obtained
from the apparently normal adjacent kidney tissue. One
further area of unaffected kidney was biopsied without a
specimen of the appropriate tumour being obtained.
Histologic sections
The freezing, section cutting and indirect immunoperoxidase
staining techniques employed were as previously described
(Umpleby et al., 1985).
Monoclonal antibodies
MoAb HLe-I anti-PBL and anti-thymocyte, UCHT-l anti-
T3, UCHT-4 anti-T8 and MASO17 anti-HLA-A, B,C have
previously been described (Umpleby et al., 1985). In addition
the following MoAbs were also used to stain sections:
M707 (Dakopatts, Dako Ltd., High Wycombe, Bucks,
UK). An 1 gGI antibody reactive with an antigen T8 (mol.
wt-33,000) present on suppressor/cytotoxic T lymphocytes.
Its specificity is identical to that of two other commercial
antibodies OKT-8 (Ortho) and anti-Leu 2a (Beckton and
Dickinson).
M716 (Dakopatts). An 1 gGI kappa antibody reactive with
an antigen T4 (mol. wt-55,000) present on most
helper/inducer T cells. This antigen appears early in
intrathymic differentiation of T cells and is initially co-
expressed with T8 and T6 antigens on cortical thymocytes.
The antigen recognised is also found in cells of
monocyte/macrophage origin.
M718 (Dakopatts). An 1 gGI kappa antibody reactive with
human macrophages. The antigen recognised is so far
unidentified.
M704 (Dakopatts). An 1 gG2a antibody which reacts with
an antigen present on the ,B chain of all HLA-DR (class II
MHC) molecules. Thus B lymphocytes, activated T cells,
reticulum cells in T cell regions, Langerhans cells, macro-
phages and endothelial cells are labelled by this antibody.
Grading ofstaining with MoAb
The whole of each section was examined and the degree of
staining of the appropriate cells and the number of cells
stained by a particular MoAb was estimated by eye as
follows: 4 (heavy), 3 (moderate), 2 (few or light),
(occasional) and 0 (nil).
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Results
Clinico-pathologicalfeatures ofthe patients studied
The survival of the patients was in general related to the
initial degree of tumour spread. In particular, patients 1 and
2 did well and patients 6, 8 and 10 did not (Table I). Patient
3 is an exception to this rule, and patient 5, although he
developed a carcinoma of the oesophagus, showed no
recurrence of his renal carcinoma after 1 year and 11
months.
Stainingfor class I and II MHC antigens
The glomeruli of the normal kidney remnant were well
stained with MAS-017 (anti class I MHC Ag) and M704
(anti class II MHC Ag) in all cases (Table II). Staining of
the proximal convoluted tubules was more variable being
positive in 4 of 6 kidneys for anti class I and 5 of 6 for anti
class II MHC (Table II). By contrast there was no staining
of renal carcinoma cells by either MoAb in these 6 cases
(Table II). The contrast between expression of class I and
class II MHC Ag on normal kidney tubules and their
absence from the carcinoma cells is well illustrated by patient
1, in whom a small area of carcinoma was found adjacent to
the normal kidney tissue (Figures 1 and 2). In 2 further
patients, 3 and 9, 'normal' kidney was not examined but in
patient 3 the carcinoma cells expressed both class I and II
MHC Ag (Figures 3 and 4) (grade 2-4) whilst class I Ag was
weakly expressed in patient 9 (grade 1) (Table III).
Staining ofmononuclear cell infiltrate
In both normal kidney and renal carcinoma tissue (Table
IV), there was a pronounced infiltration with leucocytes
(HLe-I grade 3-4) which were scattered diffusely between
the tubules in normal kidney or between the neoplastic cells
in carcinomas. In only 1 of 6 normal kidneys were the
mononuclear cells T lymphocytes. Similarly in only patients
3 and 9 were the mononuclear cells infiltrating the
carcinoma T lymphocytes (Table III). It was in these cases
that the carcinoma cells expressed MHCAg.
Infiltration with macrophages
Staining with MoAb M718 (anti Mo) showed Mo
infiltration, grade 2-3 in 5 of 7 normal kidney biopsies. A
similar Mo infiltration was seen in 7/10 renal carcinomas
(Table IV), the Mo being diffusely scattered among the
neoplastic cells, (Figure 5). The Mo stained also with MoAb
MAS-017 and M704. The degree of Mo infiltration was not
correlated to degree of tumour necrosis seen macroscopically
(Table I).
Discussion
In normal kidneys HLA-ABC Ag were expressed on the
glomeruli and intertubular capillaries whilst the tubules
showed intracellular staining (Fuggle et al., 1983). HLA-DR
Ag was also consistently present on the glomeruli and
Table I Details of the 10 patients with renal cell carcinoma
Condition of Tumour Clinical
residual size Degree of Macroscopic Tumour outcome
No. Age Sex 'normal'kidney (cm) tumour spread haemorrhage necrosis Histology post-opa
1 68 M Moderately Confined to No Clear cell Ca A&W
severe kidney 2 years
pyelonephritis
2 52 F Focal chronic 30 x 12 x 15 Confined to No + + Tubopapillary renal Ca A&W
interstitial kidney 1 yr 8mo
nephritis
3 68 F Normal 7 x 7 x 8 Penetrated renal No + Clear cell Ca A&W
capsule, invaded 2 years
renal vein
4 70 M Focal chronic 8 x 6 x 4 Invaded renal + + Clear cell Ca A&W
inflammation vein & IVC 1 yr 9mo
5 70 M Focal, tubular 6 x 6 x 6 Penetrated renal + + + +++ Clear cell Ca Alive
atrophy with capsule, invaded l yr 1lmo
fibrosis renal vein with Ca
oesophagus
6 61 M Mild 10x5x9 Penetrated renal + + Clear cell Ca Died IOmo
interstitial capsule pulmonary
fibrosis, chronic & cerebral
inflammatory metastases
reaction
7 48 M Normal 14x 12x7 Involved capsule + + No Clear cell Ca A&W
1 yr 1 mo
8 64 M Normal 9cm Involved capsule ++ + +++ Clear cell Ca admixed Progressive
max & invaded renal with tumour giant cells disease
diameter vein, bony & Ca cells with granular 5mo
metastases eosinophilic cytoplasm.
Nuclear pleomorphism
9 77 F Nephritis 15 x 11 x 8 Penetrated renal + + + + Moderately Died
capsule & involved differentiated clear 2 days
splenic capsule, cell Ca
invaded renal vein
10 65 M Normal 12x12x11 Penetratedrenal +++ +++ ClearcellCa 2mo
capsule, invaded pulmonary
renal vein. One metastases
lymph node Died 5mo
involved
aRadical nephrectomy; + Minimal; + + Moderate; + + + Marked.MHC ANTIGENS AND LEUCOTYPE INFILTRATION IN RENAL CANCER 435
Figure 1 Section of kidney from patient no. 1 stained with
MoAb MAS 017 (anti class I MHC Ag). To the right is a small
area of carcinoma, the cells of which are unstained. The tissues
in the rest of the section (uninvolved kidney) strongly express
class I MHC Ag. Counterstained with Mayers Haematoxylin
(x250).
Figure 2 Section of renal carcinoma from patient no. 1 stained
with MoAb M704 (anti Class II MHC Ag). The carcinoma cells
are unstained. Counterstained with Mayers Haematoxylin
(x250).
Figure 4 Section of renal carcinoma from patient no. 3 stained
with M704. The carcinoma cell membranes show moderate
(grade 3) expression of class II MHC Ag. Counterstained with
Mayers Haematoxylin ( x 250).
Figure 5 Section of renal carcinoma from patient no. 8. Stained
with MoAb M718 (anti Mo). There is a heavy infiltration with
Mo, some dendritic, among the carcinoma cells. Counterstained




Figure 3 Section of renal carcinoma from patient no. 3 stained
with MAS 017 to show variable expression (grade 2-4) of class I
MHC Ag on the carcinoma cell membranes. Counterstained with
Mayers Haematoxylin ( x 250).436 D. HEINEMANN et al.
Table II The comparative expression of class I
and class II MHC antigens in renal carcinoma
and the adjacent 'normal' kidney
'Normal' Renal cell
Pt no. kidney carcinoma



























tubule; Tu=Tumour. Grade of MHC Ag
expression: 4=marked; 3=moderate; 2=light;
- =occasional; 0=nil.
Table III Degrees of membrane staining by MoAba among tumour




UCHT-1 UCHT-4 M707 class I class II
Carcinoma Anti T3 Anti T8 Anti T8 MHC MHC
3 2-3 0 1 Tu2-4 Tu3
9 2-3 2-3 3 Tul TuO
aSee footnote to Table II.
Table IV Degree of membrane staining by MoAb among tumour
cells and mononuclear cell inflltrates in 8 renal cell carcinomasa
UCHT-J UCHT-4 M707 M716 M718
Patient no." HLe-J Anti T3 Anti T8 Anti T8 Anti T4 Anti Mo
1 3 1 1 2 0 3
2 2-3 1 1 1 1 2
4 3 1 0 2 1 2
5 3 1-2 1 1 0 3-4
6 3 1 0 0 1 1
7 2-3 1 1 0 0 2-3
8 4 2 1 ND 1 4
10 4 1 1 1 0 1
intertubular capillaries. However, in the proximal tubules
expression was variable. Among 46 kidneys there were 27
positive, 1-1 negative and 8 weakly positive. Staining with the
MoAb was intracellular extending throughout the cytoplasm.
Renal cell carcinomas arise from the epithelial cells lining
the proximal convoluted tubules (Borowitz et al., 1986).
Thus failure to express these antigens by the carcinoma cells
from those kidneys where the 'normal remnant' showed
positive staining would imply their loss during the process of
neoplastic transformation. In one patient (no. 3) where this
was not so, the degree of class I MHC expression was
heterogeneous. Natali et al. (1984) reported the expression of
class I MHC Ag, in 9 of 10 renal cell carcinomas. However
only in I of these tumours did the staining by anti HLA-
ABC Ab have a cytoplasmic distribution similar to that of
normal proximal tubules. Natali et al. (1984) reported the
expression of HLA-ABC Ag in tumours to be dependent on
the MoAb used. Thus the ability of MAS-017 and M704, in
the present study, to detect class I and II MHC Ag in
'normal kidney' but not on the appropriate tumour cells is
critical in sustaining the hypotheses of Ag loss on malignant
transformation.
In keeping with the poor expression of MHC antigens by
the carcinoma cells, there was little infiltration of the tumour
by cells of the T lymphocyte series. This may be contrasted
with the findings for other tumours, cited above. The
exceptions were patients 3 and 9 in whom the tumour cells
expressed MHC antigens in varying degrees. The favourable
outcome (Table I) in patient 3, despite the degree of initial
tumour spread, is of interest in this context. The recognition
of any tumour associated antigens by cytotoxic T lympho-
cytes of the host occurs in association with recognition of
self MHC Ag (Meuer et al., 1982; Wallace et al., 1982). Thus
failure to express MHC would preclude an immune response
(mediated by this effector cell population) of the patient to
the tumour. This in turn would mitigate against the efficacy
of renal artery embolisation, which produces in situ tumour
necrosis in inducing such a response. Indeed it has been
reported that there is a decrease in the helper T lymphocyte
subset in the blood of patients with renal cell carcinoma, a
defect which significantly improved one week after nephrec-
tomy alone, but not when pre-operative embolisation was
also performed (Ritchie et al., 1984). In an animal model a
relationship was found between abnormalities in the
expression of MHC Ag and metastatic spread (De Baetseiler
et al., 1980).
It must be emphasised, that other classes of anti-tumour
effector cell, specifically natural killer cells, lymphokine
activated killer cells and macrophages do not require
concomitant recognition of MHC antigens to be effective.
The majority of tumours indeed, showed a marked
infiltration with macrophages. They could be scavengers
responding to the presence of necrotic tissue. However, there
was no correlation between macroscopic evidence of tumour
necrosis and macrophage infiltration (Tables I and IV).
The findings of the present experiments suggest two
approaches to immunotherapy for renal cell carcinoma. First
to induce the expression of MHC Ag by the carcinoma cells
and second to increase the degree of macrophage infiltration
of the tumour.
We thank Dr P.C.L. Beverley for his generous gift of monoclonal
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for their range of monoclonal antibodies. Material from patients 4, 5
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Urology, University of Oxford.
aSee footnote to Table II; 'In addition to the patients listed in
Table II nos 2 and 6 did not express class I or II MHC on renal
carcinoma cells.MHC ANTIGENS AND LEUCOTYPE INFILTRATION IN RENAL CANCER 437
References
BAHN, A.K. & DES MARIS, C.L. (1983). Immunohistologic
characterization of major histocompatibility antigens and
inflammatory cellular infiltrate in human breast cancer. J. Natl
Cancer Inst., 71, 507.
BOROWITZ, M.J., WEISS, M.A., BOSSEN, E.H. & METZGAR, R.S.
(1986). Characterisation of renal neoplasms with monoclonal
antibodies to leucocyte differentiation antigens. Cancer, 57, 251.
DE BAETSEILER, P., KATZAV, P., GORELIKS, S., FELDMAN, M. &
SEGAL, S. (1980). Differential expression of H-2 gene products in
tumour cells associated with their metastatogenic properties.
Nature, 288, 179.
FUGGLE, S.V., ERRASTI, P., DAAR, A.S., FABRE, J.W., TING, A. &
MORRIS, P.J. (1983). Localisation of major histocompatibility
complex (HLA-ABC and DR) antigens in 46 kidneys.
Transplantation, 35, 385.
HOLLAND, J.M. (1973). Cancer of the kidney - natural history and
staging. Cancer, 32, 1030.
KABAWAT, S.E., BAST, R.C., WELCH, W.R., KNAPP, R.C. & BHAN,
A.K. (1983). Expression of major histocompatibility antigens and
nature of inflammatory cellular infiltrate in ovarian neoplasms.
Int. J. Cancer, 32, 547.
KAISARY, A.V., WILLIAMS, G. & RIDDLE, P.R. (1984). The role of
preoperative embolisation in renal cell carcinoma. J. Urol., 131,
641.
KANTOR, A.F. (1977). Current concepts in the epidemiology and
aetiology of primary renal cell carcinoma. J. Urol., 117, 415.
KORNSTEIN, M.J., BROOKS, J.S. & ELDER, D.E. (1983).
Immunoperoxidase localisation of lymphocyte subsets in the host
response to melanoma and nevi. Cancer Res., 43, 2749.
MEUER, S.C., SCHLOSSMAN, S.F. & REINHERZ, E.L. (1982). Clonal
analysis of human cytotoxic T lymphocytes: T4+ and T8+
effector cells recognise products of different histocompatibility
complex regions. Proc. Natl Acad. Sci. USA, 79, 4395.
MIDDLETON, R.G. (1967). Surgery for metastatic renal cell
carcinoma. J. Urol., 97, 973.
NATALI, G., BIGOTTI, A., NICOTRA, M., VIORA, M., MANFREDI, D.
& FERRONE, S. (1984). Distribution of human Class I (HLA-
ABC) histocompatibility antigens in normal and malignant
tissues of monolymphoid origin. Cancer Res., 44, 4679.
NURMI, J. (1984). Prognostic factors in renal carcinoma. An
evaluation of operative findings. Br. J. Urol., 56, 270.
RITCHIE, A.W.S., JAMES, K., MICKLEM, H.S. & CHISHOLM, G.D.
(1984). Lymphocyte subsets in renal carcinoma - a sequential
study using monoclonal antibodies. Br. J. Urol., 56, 140.
UMPLEBY, H.C., HEINEMANN, D., SYMES, M.O. & WILLIAMSON,
R.C.N. (1985). Expression of histocompatibility antigens and
characterisation of mononuclear cell infiltrates in normal and
neoplastic colorectal tissue of humans. J. Natl Cancer Inst., 74,
1161.
WALLACE, L.E., RICKINSON, A.B., ROWE, M. & EPSTEIN, M.A.
(1982). Epstein-Barr Virus specific cytotoxic T cell clones
restricted through a single HLA antigen. Nature, 297, 413.
WHITWELL, H.M., HUGHES, H.P.A., MOORE, M. & AHMED, A.
(1984). Expression of major histocompatibility antigens and
leucocyte infiltration in benign and malignant human breast
disease. Br. J. Cancer, 49, 161.
WOODRUFF, M.F.A. (1980). The interaction of cancer and host.
Grune & Stratton: New York.
F